Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

116.97
Delayed Data
As of Mar 24
 +0.17 / +0.15%
Today’s Change
92.28
Today|||52-Week Range
152.30
+11.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues265.1M233.8M228.8M220.4M
 
 
 
 
 
Cost of Goods Sold37.2M47.2M47.7M49.4M
 
 
 
 
 
Depreciation And Amortization3.5M3.7M3.7M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income224.3M182.9M177.4M167.3M
 
 
 
 
 
General Expenses42.5M40.2M35.7M38.3M
 
 
 
 
 
Research And Development19.9M17.9M14.8M18.0M
 
 
 
 
 
Total Operating Expenses83.3M91.1M87.2M91.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income181.8M142.7M141.6M129.0M
 
 
 
 
 
Extraordinary Charge-95.0K-108.0K-76.0K0.00
 
 
 
 
Other Expenses-46.6M-2.2M18.0M31.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income138.0M140.4M159.5M160.5M
 
 
 
 
 
Income Taxes-23.0M-30.4M-35.6M-20.5M
 
 
 
 
 
Minority Interest-65.0K-4.0K-243.0K-94.0K
 
 
 
 
 
Discontinued Operations-34.0K-101.0K-76.0K-137.0K
 
 
 
 
 
Net Income115.0M109.9M123.7M139.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.4M41.3M41.0M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.4M41.3M41.0M
 
 
 
 
 
 
Earnings Per ShareEPS$2.68$2.59$3.00$3.42
 
 
 
 
 
EPS Diluted$2.68$2.59$2.99$3.41